Petco Health and Wellness Company, Inc. filings document the formal disclosures of a pet specialty retailer with Class A common stock listed on Nasdaq under WOOF. Its Form 8-K reports cover operating results, earnings presentations, Regulation FD updates, fiscal outlooks and material events tied to the company's retail, services and digital pet-care business.
Petco's regulatory record also includes capital-structure disclosures for credit agreement amendments, term loan refinancing, senior secured notes due 2031, subsidiary guarantees and collateral priorities. Governance filings document board leadership changes and related compensatory arrangements, while exhibit filings preserve press releases, agreements and other materials incorporated into the company's public record.
Petco Health and Wellness Company, Inc. filed a current report to share that it will participate in the 32nd Annual Goldman Sachs Global Retailing Conference. The presentation is scheduled for September 4, 2025 at approximately 1:50 p.m. Eastern Time.
A live webcast of Petco’s presentation, and a replay available about two hours later, will be accessible through the company’s investor relations website at ir.petco.com. The company also issued a press release dated August 21, 2025, which is included as an exhibit to this report.
On 1 Aug 2025, Petco Health & Wellness (WOOF) CEO/director Joel D. Anderson purchased 1,100 Class A shares at $2.48 through the company’s 2021 Employee Stock Purchase Plan, a transaction exempt under Rule 16b-3.
Post-purchase, Anderson’s direct stake is 3,226,281 shares, comprising 2,712,719 RSUs plus 513,562 unrestricted shares. He also reports indirect holdings of 853,304 shares (2020 Trust), 724,910 shares (2025 Trust) and 7,874 shares held by his son. No derivative securities were bought or sold.
The added shares increase his total beneficial ownership marginally—about 0.04 % of his direct position—but insider buys generally signal management confidence and may be viewed positively by investors.
Form 4 highlights: On 07/24/2025 Petco Health & Wellness (WOOF) director Rajendra M. Mohan received 43,422 restricted stock units (RSUs) under the 2021 Equity Incentive Plan. Each RSU converts into one Class A share; vesting occurs at the next annual shareholder meeting or by 07/24/2026, whichever comes first. The grant was recorded at $0 purchase price, a standard equity-compensation award.
Following the transaction, Mohan now reports 523,027 directly held Class A shares.
Notable disclosure: Since the last filing Mohan forfeited 631,914 time-based RSUs. Although this forfeiture is not treated as a same-day transaction, it materially reduced his reported beneficial ownership and more than offsets the new 43k-unit grant.
No derivative securities were acquired or disposed of, and there are no changes in indirect ownership.
Form 4 – Petco Health & Wellness (WOOF)
Director Gary S. Briggs reported the acquisition of 43,422 Restricted Stock Units on 24 Jul 2025. Each RSU represents one share of Class A common stock granted under the company’s 2021 Equity Incentive Plan at no cash cost.
The RSUs will vest on the earlier of Petco’s next annual shareholder meeting or 24 Jul 2026. Following this grant, Briggs directly owns 162,761 Class A shares. No shares were sold or otherwise disposed of, and no derivative securities beyond the RSUs were involved.
The filing reflects routine board equity compensation, marginally increasing insider ownership and aligning the director’s incentives with shareholder value.
Petco Health & Wellness Company (WOOF) – Form 4 filing, 28-Jul-2025
Director Iris Yen reported an acquisition (Code A) of 43,422 restricted stock units (RSUs) on 24-Jul-2025 under the company’s 2021 Equity Incentive Plan. Each RSU converts 1-for-1 into Class A common shares at no cost to the insider. The award vests on the earlier of the next annual shareholder meeting or 24-Jul-2026, encouraging one-year board-level alignment with shareholders.
Post-grant holdings:
- Direct: 145,787 Class A shares
- Indirect: 1,983 shares held via the Yen-Geniblazo Family Trust
Petco Health & Wellness Company, Inc. (WOOF) – Form 4
Chief Legal Officer & Secretary Giovanni Insana reported a Code F transaction on 21 Jul 2025. Code F denotes issuer share withholding to satisfy taxes due upon vesting of restricted stock units (RSUs); no open-market trade occurred. 1,083 Class A shares were withheld at an implied $3.30 per share.
Following the settlement, Insana’s beneficial ownership stands at 469,064 Class A shares, which includes 369,727 outstanding RSUs granted under the 2021 Equity Incentive Plan. Because the transaction is administrative and represents less than 0.3 % of his total holdings, it does not materially alter the executive’s economic exposure. The filing is therefore viewed as routine and low-impact for investors.
Petco Health & Wellness Company, Inc. (WOOF) – Form 4 insider filing, 24 Jun 2025
Director Iris Yen reported the acquisition of 20,576 Class A common shares on 20 Jun 2025 at an indicated value of $2.47 per share (transaction code “A” indicates a stock grant/award, not an open-market purchase). Following the transaction, Yen’s direct ownership rose to 102,365 shares; an additional 1,983 shares are held indirectly through the Yen-Geniblazo Family Trust. The filing notes that 49,254 of the directly held shares are restricted stock units (RSUs) issued under the company’s 2021 equity plan, each convertible into one share upon vesting.
The grant increases the director’s total reported beneficial stake by roughly 25% versus pre-grant levels (derived from disclosed balances). While insider acquisitions can signal confidence, the use of RSU awards means the transaction reflects routine board compensation rather than discretionary buying. No sales were reported, and there are no accompanying derivative transactions. Overall, the filing modestly deepens insider alignment but is unlikely to be materially impactful to the company’s capital structure or trading dynamics given Petco’s ~300 million outstanding shares.